Skip to content

434-923-6020
info@tegvirginia.com

Search for:

About TEG
Services
- Diabetes Simulation
- Diabetes Simulation of Artificial Pancreas System
Software
Resources
Contact
- Contact Info
- User Surveys
Sign in
- Have An Account?
- Register

The Epsilon Group > About TEG > Our Collaborators

Our Collaborators

This content is password protected.

Important!!!
If you are about to download a product…
Please note that a valid license must be obtained prior to any product download. Contact TEG for the licensing information.

To continue to the page, please enter the special passcode below:
(NOT your login password)

Password:

About TEG

Our Vision
Our People
Our Collaborators

Development Timelines


JUL 2008	Accepted by the FDA as a subsitute for pre-clinical trails.
AUG 2010	Licensed from the University of Virginia Patent Foundation
JAN 2012	Enabled the first client filling of a pre-clinical IDE approved by FDA
APR 2014	• Improved glucose kinetics in hypoglycemia • Glucagon kinetics, secretion and action models, and subcutaneous transport • Improved rules for determining insulin to carbs ratio (CR) and correction factor (CF) • Age of diagnosis/onset • Fully compatiable to
AVAILABLE in DMMS.R software	✓ Improved software runtime ✓ Additional computational features and options ✓ T2DM and Pre-DM modeling capabilities


JUN 2011	Licensed from Univ. of Washington Center for Commercialization
JAN 2012	Windows 7 compatability with new software functionality and an enhanced user interface
AUG 2012	Experiment simulation, sensitivity plots and batch processing
Nov 2012	• v2.3 for Mac • Improved graphical presentation • Automatic differentiation and sensitivity analysis capabilities • Glucose Insulin Model • Instruction webinars
COMING SOON	✓ Speed improvements ✓ Monte Carlo simulation

© 2017. The Epsilon Group. All rights reserved.

Proudly powered by WordPress | Education Hub by WEN Themes

Announcing DMMS.R, a new research tool for Diabetes Simulation

Designed to meet the needs of both academic and commercial researchers, the DMMS for Research provides a powerful but easy-to-use platform for conducting simulations on Type 1, Type 2, and Pre-diabetic subjects.

Feature highlights:

Available for PC and Mac!
T1/T2/Pre-DM populations (larger, FDA-accepted T1 populations also available when TEG is employed to provide simulation services)
Platform independent.
Custom user plug-ins support specific simulation needs

Learn more about DMMS.R…

Contact TEG Today